References
Boultwood J, Wainscoat JS (2007) Gene silencing by DNA methylation in haematological malignancies. Br J Haematol 138:3–11 doi:10.1111/j.1365-2141.2007.06604.x
Griffiths EA, Gore SD (2008) DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes. Semin Hematol 45:23–30 doi:10.1053/j.seminhematol.2007.11.007
Raj K, John A, Ho A, Chronis C, Khan S, Samuel J et al (2007) CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine. Leukemia 21:1937–1944 doi:10.1038/sj.leu.2404796
Brakensiek K, Wingen LU, Langer F, Kreipe H, Lehmann U (2007) Quantitative high-resolution CpG Island Mapping with Pyrosequencing™ reveals disease-specific methylation patterns of the CDKN2B gene in myelodysplastic syndrome and myeloid leukemia. Clin Chem 53:17–23 doi:10.1373/clinchem.2007.072629
Tessema M, Langer F, Dingemann J, Ganser A, Kreipe H, Lehmann U (2003) Aberrant methylation and impaired expression of the p15(INK4b) cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML). Leukemia 17:910–918 doi:10.1038/sj.leu.2402891
Acknowledgements
This study was supported by a grant from the Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung (to UL and HK).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lehmann, U., Dobbelstein, C., Fenner, M. et al. Complete cytogenetic remission after decitabine treatment in a patient with secondary AML harbouring high p15 INK4b gene methylation and high global DNA methylation. Ann Hematol 88, 275–277 (2009). https://doi.org/10.1007/s00277-008-0584-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-008-0584-7